Related Experiment Videos
Melatonin receptors: potential targets for central nervous system disorders
1Central Nervous System Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492, USA.
Expert Opinion on Investigational Drugs
|April 1, 1997
Summary
Melatonin research is advancing rapidly due to new melatonin receptor discoveries. Developing selective drugs is key to understanding melatonin
Area of Science:
- Neuroscience
- Endocrinology
- Pharmacology
Background:
- The pineal hormone melatonin has garnered significant scientific and public attention.
- Recent molecular cloning of melatonin receptors has spurred renewed research interest.
- Numerous physiological effects are linked to melatonin, but receptor subtype roles remain unclear.
Purpose of the Study:
- To review the molecular and pharmacological characteristics of melatonin receptors.
- To explore the potential clinical applications of melatonin receptor ligands.
- To discuss advancements in identifying selective ligands for melatonin receptors.
Main Methods:
- Literature review of molecular and pharmacological studies.
- Analysis of scientific and lay press coverage.
- Assessment of progress in ligand development.
Main Results:
- Melatonin receptor research is experiencing a resurgence.
- Lack of selective agonists/antagonists hinders understanding of receptor functions.
- Progress is being made in developing selective ligands.
Conclusions:
- Further research into melatonin receptor subtypes is crucial.
- Selective ligands are essential for elucidating melatonin's physiological roles.
- Potential clinical applications of melatonin receptor ligands warrant investigation.